Showing 1321-1330 of 2101 results for "".
- ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals in Korea and Hyaluronic Acid (HA) Dermal Fillers in Brazilhttps://modernaesthetics.com/news/exocobio-obtains-gmp-licenses-for-exosome-biopharmaceuticals-in-korea-and-hyaluronic-acid-ha-dermal-fillers-in-brazil/2473370/ExoCoBio announced that it has obtained the "Certificate of Advanced Biopharmaceutical Manufacturing" from the Ministry of Food and Drug Safety in Korea, and the "HA Filler GMP Certification" from the Brazilian Food and Drug Health Monitoring Agency (ANVISA). Accordi
- Neauvia Granted CE Marking Under the E.U.’s New MDR for Facial Dermal Filler Linehttps://modernaesthetics.com/news/neauvia-granted-ce-marking-under-the-eus-new-mdr-for-facial-dermal-filler-line/2473362/Neauvia scored CE marking under the European Union’s new MDR (Medical Device Regulation) for its range of facial dermal fillers products, making it the first medical aesthetics business to receive such certification in Europe. The new regulation aims to create ‘a robus
- Industry Vet Crystal Muilenburg Joins Elevai’s Board of Directorshttps://modernaesthetics.com/news/industry-vet-crystal-muilenburg-joins-elevais-board-of-directors/2473357/Crystal Muilenburg is the newest member of Elevai’s Board of Directors. A former Evolus and Allergan executive, Muilenburg will play a key role in supporting the Elevai management team as it commercializes Elevai’s flagship exosome product line while driving t
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Endo Pulls Qwo from Markethttps://modernaesthetics.com/news/endo-pulls-qwo-from-market/2473339/Endo International plc is ceasing the production and sale of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes) in light of market concerns about the extent and variability of bruising following initial treatment as well as the potential for prolonged skin discoloratio
- Galderma Celebrates Self-Expression at Miami Art Week 2022https://modernaesthetics.com/news/galderma-celebrates-self-expression-at-miami-art-week-2022/2473335/Galderma is the exclusive aesthetic injectables sponsor of the 21st annual SCOPE Miami Beach 2022 art show. Galderma will be highlighting its aesthetics portfolio – Restylane, Dysport (abobotulinumtoxinA) and Sculptra – and hosting a variety of
- Rebrand Alert: Crown's ProGen PRP Advantage Is Now ProGen PRP Eclipsehttps://modernaesthetics.com/news/rebrand-alert-crowns-progen-prp-advantage-is-now-progen-prp-eclipse/2473324/Crown Aesthetics completed the rebranding of ProGen PRP Advantage, now renamed ProGen PRP Eclipse. ProGen PRP Eclipse is a one-spin system that features 15 mL and 30 mL tubes, yielding 7-15 mL of Platelet Rich Plasma. "Crown's commitment to best-in-class service
- Evio Beauty Supports Domestic Violence Survivorshttps://modernaesthetics.com/news/evio-beauty-supports-domestic-violence-survivors/2473319/Evio Beauty is teaming up with FreeFrom, a US-based non-profit organization dedicated to helping survivors of intimate partner violence achieve economic justice and long-term financial stability. Evio will donate one dollar from every sale of their Lip Serum (in any shade) to FreeFrom.
- U.S. FDA Clears EndyMed’s Pure Laser Hair Removal Devicehttps://modernaesthetics.com/news/us-fda-clears-endymeds-pure-laser-hair-removal-device/2473318/The US Food and Drug Administration has cleared Endymed Ltd’s Pure Laser hair removal device for the marketing and sales. The Pure Laser was developed in the Company's labs by its subsidiary Endymed Medical Ltd. The Company intends to commence marketing in the US th
- New Indications for SkinPen in the EU and UKhttps://modernaesthetics.com/news/new-indications-for-skinpen-in-the-eu-and-uk/2473310/Crown Aesthetics’ SkinPen Precision scored three new approved indications in the EU and UK. The new&